Patent 7374933 was granted and assigned to Lexicon Pharmaceuticals, Inc. on May, 2008 by the United States Patent and Trademark Office.
Novel human polynucleotide and polypeptide sequences are disclosed that can be used in thereapeutic, diagnostic, and pharmacogenomic applications.